Hartford CFO logs equity award, tax-share disposition

Q: What period did the certified HIG performance share award cover for the CFO?

The certified performance share award covered the January 1, 2023 through December 31, 2025 performance period. The company’s Compensation and Management Development Committee certified payout levels based on performance versus pre-established objectives, and the award was settled in shares of common stock.

HARTFORD INSURANCE GROUP, INC.

Filing Impact

(Very High)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

HARTFORD INSURANCE GROUP, INC. EVP and CFO Beth Ann Costello reported equity compensation transactions tied to a certified performance share award covering the January 1, 2023 through December 31, 2025 period. Performance shares were settled in common stock, increasing her direct common holdings to 106,300.282 shares before taxes.

On February 18, 2026, 13,312 common shares were disposed of back to the company at $143.53 per share to satisfy tax withholding obligations arising from the award certification. After this tax-withholding disposition, she directly owns 92,988.282 common shares, in addition to multiple vested and vesting stock option grants.

Insider Trade Summary

28,726.676 shares exercised/converted

Exercise 12 txns

Insider Costello Beth Ann

Role EVP and CFO

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	13,312	$143.53	$1.91M
Grant/Award	Performance Shares	28,726.676	$0.00	$0.00
Exercise	Performance Shares	28,726.676	$0.00	$0.00
Exercise	Common Stock	28,726.676	$0.00	$0.00
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--

Holdings After Transaction: Performance Shares — 0 contracts (Direct); Common Stock — 92,988.282 shares (Direct); Stock Option — 457,551 contracts (Direct)

Footnotes (11)

F1. On February 17, 2026, the Company's Compensation and Management Development Committee certified a performance share payout based on the level of the Company's performance relative to pre-established objectives for the January 1, 2023 through December 31, 2025 performance period. The performance shares were paid in shares of the Company's common stock.
F2. Transaction involving a disposition to the Company of equity securities to cover tax withholding obligations arising from the performance share certification reported on this Form 4, in accordance with the Company's administrative rules.
F3. The closing price of the Company's common stock on February 17, 2026, the day of certification.
F4. The options became fully exercisable on February 26, 2022, the third anniversary of the grant date.
F5. The options became fully exercisable on February 23, 2024, the third anniversary of the grant date.
F6. The options became fully exercisable on February 27, 2021, the third anniversary of the grant date.
F7. The options became fully exercisable on February 25, 2023, the third anniversary of the grant date.
F8. The options became fully exercisable on February 23, 2025, the third anniversary of the grant date.
F9. One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date.
F10. One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date.
F11. One-third of the options will become exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did HIG EVP and CFO Beth Ann Costello report?

Beth Ann Costello reported a certified performance share award that converted into common stock and a related tax-withholding disposition. Performance shares for the 2023–2025 period were paid in common stock, with some shares returned to the company to cover tax obligations.

How many Hartford (HIG) common shares did the CFO dispose of for taxes?

She disposed of 13,312 common shares back to the company to cover tax withholding obligations. The disposition price was $143.53 per share, matching the company’s closing stock price on February 17, 2026, the day the performance shares were certified.

What is Beth Ann Costello’s Hartford (HIG) common stock ownership after these Form 4 transactions?

After the reported equity transactions, Beth Ann Costello directly owns 92,988.282 shares of Hartford’s common stock. This figure reflects the net position following the conversion of performance shares into common stock and the subsequent tax-withholding disposition to the company.

Were the HIG CFO’s reported dispositions open-market sales of common stock?

No. The disposition involved shares delivered back to the company to satisfy tax withholding obligations. The transaction was described as a disposition to the company under its administrative rules, following the certification and payout of performance shares in common stock.

What types of equity awards and holdings does the HIG CFO report on this Form 4?

She reports performance shares that were granted, then exercised into common stock, and subsequent common stock holdings. Multiple stock option grants are also listed, many fully exercisable, with specified tranches becoming exercisable on future February anniversaries of the respective grant dates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 02/19/2026 - 04:07 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Costello Beth Ann

(Last)

(First)

(Middle)

ONE HARTFORD PLAZA

(Street)

HARTFORD

06155

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
HARTFORD INSURANCE GROUP, INC. [ HIG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP and CFO

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/17/2026		M		28,726.676	A	$0⁽¹⁾	106,300.282	D
Common Stock	02/18/2026		F⁽²⁾		13,312	D	$143.53⁽³⁾	92,988.282	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Performance Shares	⁽¹⁾	02/17/2026		A		28,726.676		⁽¹⁾	⁽¹⁾	Common Stock	28,726.676	$0.0000	28,726.676	D
Performance Shares	⁽¹⁾	02/17/2026		M			28,726.676	⁽¹⁾	⁽¹⁾	Common Stock	28,726.676	$0.0000	0.0000	D
Stock Option	$49.01							⁽⁴⁾	02/26/2029	Common Stock	75,790		75,790	D
Stock Option	$51.87							⁽⁵⁾	02/23/2031	Common Stock	67,204		67,204	D
Stock Option	$53.81							⁽⁶⁾	02/27/2028	Common Stock	63,194		63,194	D
Stock Option	$55.27							⁽⁷⁾	02/25/2030	Common Stock	71,318		71,318	D
Stock Option	$69.41							⁽⁸⁾	02/23/2032	Common Stock	75,483		75,483	D
Stock Option	$78.28							⁽⁹⁾	02/28/2033	Common Stock	57,492		57,492	D
Stock Option	$95.74							⁽¹⁰⁾	02/27/2034	Common Stock	25,223		25,223	D
Stock Option	$116.41							⁽¹¹⁾	02/25/2035	Common Stock	21,847		21,847	D

Explanation of Responses:

1. On February 17, 2026, the Company's Compensation and Management Development Committee certified a performance share payout based on the level of the Company's performance relative to pre-established objectives for the January 1, 2023 through December 31, 2025 performance period. The performance shares were paid in shares of the Company's common stock.

2. Transaction involving a disposition to the Company of equity securities to cover tax withholding obligations arising from the performance share certification reported on this Form 4, in accordance with the Company's administrative rules.

3. The closing price of the Company's common stock on February 17, 2026, the day of certification.

4. The options became fully exercisable on February 26, 2022, the third anniversary of the grant date.

5. The options became fully exercisable on February 23, 2024, the third anniversary of the grant date.

6. The options became fully exercisable on February 27, 2021, the third anniversary of the grant date.

7. The options became fully exercisable on February 25, 2023, the third anniversary of the grant date.

8. The options became fully exercisable on February 23, 2025, the third anniversary of the grant date.

9. One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date.

10. One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date.

11. One-third of the options will become exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.

	Anthony J. Salerno, Jr., Attorney-in-Fact	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR